Share this postCopy linkFacebookEmailNotesMoreMendelspod PodcastLong DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech 8Share this postCopy linkFacebookEmailNotesMore11×Preview0:00Current time: 0:00 / Total time: -8:12-8:12Audio playback is not supported on your browser. Please upgrade.Long DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech Theral TimpsonSep 13, 2023∙ Paid8Share this postCopy linkFacebookEmailNotesMore1ShareChapters:0:00 World’s longest oligo8:45 Why is it difficult to synthesize long DNA?12:00 Proprietary TdT conjugate16:00 A billion-dollar market24:20 The computation model and its challenges28:35 More customers using generative AIMendelspod is now reader supported. Please consider upgrading to a paid subscription for the price of a couple cof…SubscribeThis post is for paid subscribersSubscribeAlready a paid subscriber? Sign inMendelspod PodcastOffering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine.Offering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine.SubscribeListen onSubstack AppRSS FeedAppears in episodeTheral TimpsonRecent EpisodesBuilding Intuition at the Nanoscale: Steve McCloskey of Nanome on the VR Future of ScienceMay 1 • Theral TimpsonBeyond the $100 Genome--the Everyday Sequencing Revolution You Missed: Mark Budde, PlasmidsaurusApr 29 • Theral TimpsonWhat Next for LDTs? A Conversation with Sarah Overton of Velsera Apr 22 • Theral TimpsonAI’s Quiet Revolution in the Pharma Supply Chain with Chris Petersen, Scientist.comApr 17 • Theral TimpsonWe've Been Misclassifying Childhood AML for Years: Jeffery Klco, St. Jude'sApr 15 • Theral TimpsonAaron Viny: A 21-Year Leukemia Survivor on the Frontlines of Epigenetic Cancer ResearchApr 10 • Theral TimpsonToward Disease Sub-typing with Ben Busby, DNAnexusApr 3 • Theral TimpsonSynthetic Biology Ready for Its ChatGPT Moment: A Preview of SynBioBeta 2025 with John CumbersApr 1 • Theral Timpson